Browsing University of Nottingham Research Data Management Service by Subject "Subjects Allied to Medicine::Medical technology::Radiology::Radiography, diagnostic"
Now showing items 1-5 of 5
-
Clinician-patient communication of medical imaging results: a scoping review
(The University of Nottingham, 2024-04-16)This scoping review explores factors considered in the communication of medical imaging results between healthcare professionals and patients. The review forms part of a PhD research project looking at the development of ... -
Feasibility of whole-body MRI for cancer surveillance in children and young people with Ataxia Telangiectasia
(The University of Nottingham, 2023-03-10)Ataxia Telangiectasia (A-T) is an autosomal recessive disorder characterised by cerebellar degeneration, immunodeficiency, respiratory disease, radiosensitivity, and cancer susceptibility. A-T is a progressive condition ... -
Nigrosome depigmentation as seen on neuromelanin-sensitive MRI at 3T as diagnostic marker in clinical uncertain parkinsonism: analysis plan for the secondary aims of N3iPD study
(The University of Nottingham, 2023-12-01)Access to these files may be requested. Please contact Dr Xing at You.Xing@nottingham.ac.uk. In our prospective multi-centre MRI study at 3T, our primary aim was to establish the prospective diagnostic value of iron-sensitive ... -
Quantitative chemical exchange saturation transfer imaging of nuclear overhauser effects in acute ischemic stroke - underpinning data
(The University of Nottingham, 2022-03-15)Data and code required to generate figures in the paper entitled: Quantitative chemical exchange saturation transfer imaging of nuclear overhauser effects in acute ischemic stroke -
Serial 3T MRI in early Parkinson’s to validate PD progression markers: Rationale and MRI analysis plan for nigral depigmentation at baseline, 6- and 12-months’ follow-up
(The University of Nottingham, 2023-11-02)Access to these files may be requested. Please contact Dr Xing at You.Xing@nottingham.ac.uk. While NM-MRI has shown promise in diagnosing PD, its potential as a progression marker, particularly in the early stages when ...